-
-
-
-
-
-
-
Viatris Appoints Matthew J. Maletta as Chief Legal Officer
-
-
-
-
-
-
-
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
-
-
-
-
-
-
-
Viatris Announces the Pricing Terms of Maximum Tender Offer
-
-
-
-
-
-
-
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
-
-
-
-
-
-
-
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
-
-
-
-
-
-
-
Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division
-
-
-
-
-
-
-
Oyster Point Pharma Inc. (OYST) to be Acquired by Viatris (VTRS) for $11 Per Share Plus CVR
-
1,179,478 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

